文献速递头颈外科

头颈游离组织瓣术后使用酮咯酸不增加皮瓣并发症

Ketorolac Use After Head and Neck Free Tissue Transfer Is Not Associated With Increased Flap Complications.
PubMed 文献 · Head Neck · 2026-06-25

该回顾性队列研究比较头颈癌游离皮瓣术后5天内使用与未使用酮咯酸各2280例患者,发现酮咯酸未增加术后出血、皮瓣修整、血管修复、急性肾损伤和胃造瘘管放置风险,30天内并发症未增加。

要点

  • 头颈游离皮瓣术后5天内使用酮咯酸与术后出血风险降低相关(RR 0.825)。
  • 酮咯酸组皮瓣修整、血管修复、急性肾损伤和胃造瘘管放置风险均未增加。
  • 回顾性队列显示术后30天内酮咯酸不增加并发症,但需前瞻性验证。

核心结论

  • 头颈游离皮瓣术后5天内使用酮咯酸与30天内并发症增加无关。

研究设计与样本

  • 回顾性队列研究,通过ICD-10和CPT代码识别头颈癌游离皮瓣手术患者,酮咯酸组2280例,非酮咯酸组2280例。

主要发现

  • 酮咯酸与术后出血风险降低相关(RR 0.825,p=0.016)。
  • 酮咯酸与皮瓣修整风险降低相关(RR 0.767,p<0.001)。
  • 酮咯酸与血管修复风险降低相关(RR 0.528,p<0.001)。
  • 酮咯酸与急性肾损伤风险降低相关(RR 0.664,p=0.003)。
  • 酮咯酸与胃造瘘管放置风险降低相关(RR 0.884,p=0.021)。

临床怎么用

  • 头颈游离皮瓣术后可考虑使用酮咯酸,但需结合患者个体情况评估。

局限性

  • 回顾性队列设计可能存在选择偏倚和混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The primary goal of the study is to assess bleeding complications and evaluate ketorolac for its safety in cancer patients undergoing head and neck free-flap surgery. METHODS: Two cohorts of head and neck cancer patients undergoing free-flap surgery were identified using ICD-10 and CPT codes. Cohort 1 received ketorolac within 5 days of surgery (n = 2280); Cohort 2 did not receive ketorolac within 5 days of surgery (n = 2280). Postoperative hemorrhage occurrence and secondary outcomes were assessed. RESULTS: Ketorolac was not associated with increased risk of postoperative hemorrhage (RR: 0.825, p = 0.016), flap revisions (RR: 0.767, p < 0.001), blood vessel repair (RR: 0.528, p < 0.001), AKI (RR: 0.664, p = 0.003), and G-tube placement (RR: 0.884, p = 0.021). CONCLUSIONS: In this retrospective cohort, postoperative ketorolac was not associated with increased complications within the 30-day period.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Byorth JK, Soule SM, Seliger BJ, et al. Ketorolac Use After Head and Neck Free Tissue Transfer Is Not Associated With Increased Flap Complications. Head Neck. 2026. PMID: 42357844. doi:10.1002/hed.70376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。